Walleye Capital LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 134 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$3,137,000
+62.3%
1,049,059
+43.8%
0.08%
+40.0%
Q4 2021$1,933,000
+3547.2%
729,297
+2414.8%
0.06%
+400.0%
Q2 2020$53,000
-89.1%
29,000
-80.9%
0.01%
-94.7%
Q3 2018$488,000151,9230.23%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,020,719$3,746,0002.58%
Boxer Capital, LLC 1,351,137$4,959,0002.22%
Palo Alto Investors LP 5,186,088$19,033,0001.11%
DAFNA Capital Management LLC 340,000$1,248,0000.87%
SENZAR ASSET MANAGEMENT, LLC 907,203$3,329,435,0000.86%
Rhenman & Partners Asset Management AB 1,400,000$5,138,000,0000.82%
NEA Management Company, LLC 3,243,150$11,902,0000.53%
Cormorant Asset Management, LP 1,155,600$4,241,0000.47%
Ghost Tree Capital, LLC 700,000$2,569,0000.42%
Rock Springs Capital Management LP 1,810,000$6,643,0000.42%
View complete list of RIGEL PHARMACEUTICALS INC shareholders